Research Outline

Demographic Analysis


To identify the number of people being treated for diabetes, cancer, and heart disease in North America, Europe, and Australasia and including demographic information and private/public expenditure per capita.

Early Findings

Diabetes: North America


  • According to the International Diabetes Federation (IDF), the prevalence of Diabetes in North America (including the Caribbean) is 11.1% in 2019. Around 48 million people have Diabetes in this region.
  • The number of people living with Diabetes in 3 (out of 23) countries in the North American region are as follows.
United States: 30,187,500 (or 13% of prevalence in adults)
Canada: 2,603,200 (9.6% prevalence)
Mexico: 12,030,100 (14.8% prevalence)
  • The IDF further states that 37.8% of adults living with diabetes are undiagnosed. From this we can assume that 62.2% (100-37.8) of the population with Diabetes are receiving treatment.
  • Based on the above information, we can conclude that around 29.9 million people (48 million*62.2%) with Diabetes are receiving treatment in the North American region.


  • According to the IDF, the highest prevalence of Diabetes is seen in males, aged 70-79 (page 71).

Spending on Treatment

  • in 2019, USD 324.5 billion was spent on diabetes in North America (and Caribbean), which was higher than any other region in the world and corresponds to 42.7% of the total global health expenditure on Diabetes.
  • USD 294.6 billion was spent on Diabetes in the United States during 2019 and also has the highest mean expenditure per person in the region with USD 9,506, followed by Canada (USD 4,397). The lowest in the Region was Haiti (USD 142).

Other Info:

For the purpose of scoping the remaining project, we have identified the number of countries in each region to be as follows:
- North America: 23
- Europe: 44
- Australasia: 14